RAPT Therapeutics, Inc. (RAPT) Non Operating Income (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Non Operating Income for 5 consecutive years, with $1.2 million as the latest value for Q4 2024.
- Quarterly Non Operating Income fell 48.06% to $1.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2024, down 39.24% year-over-year, with the annual reading at $6.2 million for FY2024, 39.24% down from the prior year.
- Non Operating Income hit $1.2 million in Q4 2024 for RAPT Therapeutics, down from $1.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $3.1 million in Q2 2023 to a low of -$275000.0 in Q2 2022.
- Historically, Non Operating Income has averaged $988700.0 across 5 years, with a median of $496000.0 in 2020.
- Biggest YoY gain for Non Operating Income was 1309.52% in 2022; the steepest drop was 848.28% in 2022.
- Year by year, Non Operating Income stood at $549000.0 in 2020, then tumbled by 80.87% to $105000.0 in 2021, then skyrocketed by 1309.52% to $1.5 million in 2022, then skyrocketed by 58.18% to $2.3 million in 2023, then plummeted by 48.06% to $1.2 million in 2024.
- Business Quant data shows Non Operating Income for RAPT at $1.2 million in Q4 2024, $1.4 million in Q3 2024, and $1.7 million in Q2 2024.